Zdrowie i gospodarka · 08/08/2007

FDA Clears Path for Methotrexate Injection Approval

The US Food and Drug Administration (FDA) has made a determination that methotrexate injection, USP, preservative free, equivalent to 500 milligrams base/20 milliliters (25 milligrams per milliliter), was not withdrawn from sale due to safety or effectiveness concerns. This decision will enable the FDA to approve abbreviated new drug applications (ANDAs) for this product.